Document is current
Any future updates will be listed below
-
Authors
Fink, Kevin
Forster, Marie
Oettle, Matthias
Büttner, Marcel
Eze, Chukwuka
Käsmann, Lukas
Tufman, Amanda
Kauffmann-Guerrero, Diego
Bolt, Toki A.
Kovacs, Julia
Neumann, Jens
Mücke, Johannes
Heuser, Sonja
Corradini, Stefanie
Walter, Franziska
Niyazi, Maximilian
Belka, Claus
Dreyling, Martin
Fischer, Martin R.
Fleischmann, Daniel F.
-
Funding
Funding for this research was provided by:
Deutsches Krebsforschungszentrum (DKFZ)
- License Information
-
More Information
Article History
Received: 15 June 2024
Accepted: 23 July 2024
First Online: 30 August 2024
Declarations
:
: M.D. received research support from Abbvie, Bayer, BMS/Celgene, Gilead/Kite, Janssen, Lilly, and Roche. M.D. received Speakers Honoraria from Astra Zeneca, Beigene, Gilead/Kite, Janssen, Lilly, Novartis, and Roche. M.D. is part of the Scientific Advisory Board of Abbvie, Astra Zeneca, Beigene, BMS/Celgene, Gilead/Kite, Janssen, Lilly/Loxo, Novartis, and Roche. No other disclosures were reported. The project was financially supported by the medical faculty of the LMU Munich and the Virtuelle Hochschule Bayern (vhb).
